Vasopressin V2 Receptor Antagonist
- Name
- Vasopressin V2 Receptor Antagonist
- Accession Number
- DBCAT003559
- Description
Not Available
- Drugs
Drug Drug Description Tolvaptan A selective vasopressin V2-receptor antagonist to slow kidney function decline in patients at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Also used to treat hypervolemic and euvolemic hyponatremia. - Drugs & Drug Targets
Drug Target Type Tolvaptan Vasopressin V2 receptor target Tolvaptan Cytochrome P450 3A4 enzyme Tolvaptan P-glycoprotein 1 transporter Tolvaptan Vasopressin V1a receptor target